Metsera to present at goldman sachs 46th annual global healthcare conference

New york, june 10, 2025 (globe newswire) -- metsera, inc. (nasdaq: mtsr) (“metsera” or the “company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that whit bernard, its chief executive officer, will present at the goldman sachs 46th annual global healthcare conference on wednesday, june 11 at 10:00 – 10:35 a.m. edt. a live webcast and replay of the presentation will be available on the events page in the investors & news section of the metsera website at investors.metsera.com.
MTSR Ratings Summary
MTSR Quant Ranking